Doctor Sabrina Pagano

Doctor Sabrina Pagano

Geneva University Hospitals, Geneva (Switzerland)

Sabrina Pagano studied Biological Sciences with Biotechnology specialization at the University “La Sapienza” of Rome (Italy). She received her PhD in “Endocrinology and Molecular Medicine” at the medical faculty of the University “La Sapienza”. She then spent two years at the Menarini Biotech pharmaceutical company in Italy. Later she joined the group of Professor Nicolas Vuilleumier in 2008 at the Laboratory Medicine Division at the Diagnostics Department of the Geneva University Hospital (Switzerland) where she is currently head of the research lab. Her research focus is to investigate the role of the humoral autoimmunity in cardiovascular disease with a particular attention to the study of autoantibodies directed against anti-apolipoprotein A-1, the major protein fraction of HDL, as a biomarker and mediator of atherogenesis.

Presentations

Antibody against apolipoprotein-A1, Metabolic-Associated Fatty Liver Disease and cardiovascular risk: a translational study

Event: ESC Congress 2023

Topic: Lipids, Metabolism

Session: Vascular disease and perturbed lipid metabolism

Access

Autoantibodies directed against apolipoprotein-a-1 as a potential contributor to non-alcoholic fatty liver disease

Event: ESC Congress 2021 - The Digital Experience

Topic: Biomarkers

Session: Basic science e-posters

Access

Doctor Sabrina Pagano

Biography

Contributor content

Antibody against apolipoprotein-A1, Metabolic-Associated Fatty Liver Disease and cardiovascular risk: a translational study

Autoantibodies directed against apolipoprotein-a-1 as a potential contributor to non-alcoholic fatty liver disease

ESC 365 is supported by